| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: has antibacterial activity; isolated from Staphylococcus aureus; structure in first source
Also Known As:| 1. | Sostarecz, Audra Goach: 1 article (09/2007) |
| 2. | Savage, Paul B: 1 article (09/2007) |
| 3. | Byfield, Fitzroy J: 1 article (09/2007) |
| 4. | Bucki, Robert: 1 article (09/2007) |
| 5. | Janmey, Paul A: 1 article (09/2007) |
| 1. | Infection
09/01/2008
- "CONCLUSIONS: Ceragenin CSA-13 may be useful as an agent to make erythromycin effective against infections caused by multiple antibiotic resistant gram-negative bacteria. "
Order ALL the reference details at left... |
| 2. | Cystic Fibrosis (Mucoviscidosis)
09/01/2007
- "Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum."
Order ALL the reference details at left... |
| 1. | Erythromycin (Erycette)
|
| 2. | DNA (Deoxyribonucleic Acid)
|
| 3. | Actins (F Actin)
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |